Find a Commonwealth Resource
Patent AT-E400276-T1: [Translated] NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS AS ANTAGONISTS OF CELL PROLIFERATION AND INDUCTORS OF CELL DIFFERENTIATION
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Chemical patent from PubChem database. Patent Number: AT-E400276-T1. Title: Novel Pharmaceutical Composition. Filing Date: 1998-02-08. Inventors: Anderson, Robert, Davis, Linda. Abstract: The present invention relates to a novel pharmaceutical composition comprising one or more active pharmaceutical ingredients and pharmaceutically acce... IPC Classifications: C07D, A61K, A61P. This patent covers 32 claims related to 8 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E400276-T1: [Translated] NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS AS ANTAGONISTS OF CELL PROLIFERATION AND INDUCTORS OF CELL DIFFERENTIATION on the official website.
Modified Apr 29, 2026